The pharmaceutical industry is increasingly turning to emerging markets for growth opportunities, driven by factors such as population growth, rising incomes, and evolving healthcare systems. However, navigating regulatory artwork requirements in these markets poses unique challenges. This whitepaper delves into the characteristics of emerging markets, their significance in the pharmaceutical industry, and the specific challenges faced in achieving artwork compliance. It outlines key artwork requirements, including labeling and packaging specifications, language and cultural adaptations, unique legal requirements, and serialization and anti-counterfeiting measures. The paper proposes strategies for navigating artwork compliance, such as establishing market-specific artwork teams, efficient localization and translation processes, and fostering regional partnerships. By adopting a strategic approach to artwork compliance, pharmaceutical companies can successfully enter and thrive in emerging markets while ensuring regulatory compliance and patient safety.
Fill the form below to download the White Paper
